PA
MANE

Parallel Advisors’s Veradermics Inc MANE Stock Holding History

Parallel Advisors’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.4K Buy
+295
New +$27.6K ﹤0.01% 2336

Other funds holding MANE

SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Parallel Advisors's MANE Position: Q2 2026 in Review

Parallel Advisors opened a new position in Veradermics Inc (MANE) in Q2 2026: 295 shares worth $36.4K. The stake represents ﹤0.01% of the portfolio and ranks #2336 among its holdings.

148 funds tracked by Wall St. Rank hold MANE as of Q2 2026.

  • Parallel Advisors held 295 shares of Veradermics Inc worth $36.4K as of Q2 2026.
  • Veradermics Inc was a new Parallel Advisors position in Q2 2026.
  • Veradermics Inc made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #2336 holding.
  • 148 funds tracked by Wall St. Rank held Veradermics Inc as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.